Patent · US Expired

Method for expression of small antiviral RNA molecules within a cell

US7195916B2 · kind B2 · utility

38Cited by
13References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2002
Grant dateMar 27, 2007
Priority date
Expiry dateApr 26, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector. The methods can be used to express double stranded RNA complexes. Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell, that interfere with a viral life cycle by down regulating either the viral genome, a viral genome transcript, or a host cell that. In another aspect the invention provides methods for treating patients having suffering from infection, particularly infection with HIV. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.